A Rationally Designed Prodrug for the Fluorogenic Labeling of Albumin and Theranostic Effects on Drug-Induced Liver Injury DOI
Tianhong Wu, Hui Zhang, Peng Zhang

et al.

Analytical Chemistry, Journal Year: 2024, Volume and Issue: 96(8), P. 3498 - 3507

Published: Feb. 16, 2024

The development of small-molecular fluorogenic tools for the chemo-selective labeling proteins in live cells is important evaluation intracellular redox homeostasis. Dynamic imaging human serum albumin (HSA), an antioxidant protein under oxidative stress with concomitant release drugs to maintain homeostasis, affords potential opportunities disease diagnosis and treatment. In this work, we developed a nonfluorogenic prodrug named TPA-NAC, by introducing N-acetyl-l-cysteine (NAC) into conjugated acceptor skeleton. Through combined thiol amino addition, coupling HSA results fluorescence turn-on drug release. It was reasoned that restricted intramolecular motion probe microenvironment after covalent bonding inhibited nonradiative transitions. Furthermore, biocompatibility photochemical properties TPA-NAC enabled it image exogenous endogenous living wash-free manner. Additionally, released evoked upregulation superoxide dismutase (SOD), which synergistically eliminated reactive oxygen species drug-induced liver injury model. This study provides insights design new theranostic fluorescent prodrugs treatments.

Language: Английский

Emerging and Re-emerging Warheads for Targeted Covalent Inhibitors: An Update DOI

Laura Hillebrand,

Xiaojun Julia Liang,

Ricardo A. M. Serafim

et al.

Journal of Medicinal Chemistry, Journal Year: 2024, Volume and Issue: 67(10), P. 7668 - 7758

Published: May 7, 2024

Covalent inhibitors and other types of covalent modalities have seen a revival in the past two decades, with variety new targeted drugs having been approved recent years. A key feature such molecules is an intrinsically reactive group, typically weak electrophile, which enables irreversible or reversible formation bond specific amino acid target protein. This often called "warhead", critical determinant ligand's activity, selectivity, general biological properties. In 2019, we summarized emerging re-emerging warhead chemistries to cysteine acids (Gehringer, M.; Laufer, S. A. J. Med. Chem. 62, 5673−5724; DOI: 10.1021/acs.jmedchem.8b01153). Since then, field has rapidly evolved. Here discuss progress on warheads made since our last Perspective their application medicinal chemistry chemical biology.

Language: Английский

Citations

55

Hybrid Small-Molecule/Protein Fluorescent Probes DOI
Masafumi Minoshima, Shahi Imam Reja,

Ryu Hashimoto

et al.

Chemical Reviews, Journal Year: 2024, Volume and Issue: 124(10), P. 6198 - 6270

Published: May 8, 2024

Hybrid small-molecule/protein fluorescent probes are powerful tools for visualizing protein localization and function in living cells. These hybrid constructed by diverse site-specific chemical labeling approaches through reactions to exogenous peptide/small tags, enzymatic post-translational modifications, bioorthogonal genetically incorporated unnatural amino acids, ligand-directed reactions. The employed imaging trafficking, conformational changes, bioanalytes surrounding proteins. In addition, facilitate visualization of dynamics at the single-molecule level defined structure with super-resolution imaging. this review, we discuss development bioimaging applications based on hybrids.

Language: Английский

Citations

26

Chemically engineering cells for precision medicine DOI
Yixin Wang, Zhaoting Li,

Fanyi Mo

et al.

Chemical Society Reviews, Journal Year: 2023, Volume and Issue: 52(3), P. 1068 - 1102

Published: Jan. 1, 2023

This review summarizes chemical tools for cell engineering, introduces their wide application in diagnosis and therapy, discusses the challenges opportunities precision medicine.

Language: Английский

Citations

41

Reversible Dual-Covalent Molecular Locking of the 14-3-3/ERRγ Protein–Protein Interaction as a Molecular Glue Drug Discovery Approach DOI Creative Commons
B. Somsen,

Rick J.C. Schellekens,

Carlo J. A. Verhoef

et al.

Journal of the American Chemical Society, Journal Year: 2023, Volume and Issue: 145(12), P. 6741 - 6752

Published: March 16, 2023

Molecules that stabilize protein–protein interactions (PPIs) are invaluable as tool compounds for biophysics and (structural) biology, starting points molecular glue drug discovery. However, identifying initial PPI stabilizing matter is highly challenging, chemical optimization labor-intensive. Inspired by crosslinking reversible covalent fragment-based discovery, we developed an approach term "molecular locks" to rapidly access glue-like compounds. These dual-covalent small molecules reversibly react with a nucleophilic amino acid on each of the partner proteins dynamically crosslink protein complex. The between hub 14-3-3 estrogen-related receptor γ (ERRγ) was used pharmacologically relevant case study. Based focused library dual-reactive molecules, compound developed. Biochemical assays X-ray crystallographic studies validated ternary complex formation overall stabilization via dynamic crosslinking. lock selective specific 14-3-3/ERRγ complex, over other complexes. This selectivity driven interplay reactivity recognition composite binding interface. long lifetime locks enabled even in presence several competing clients higher intrinsic affinities. enables systematic, selective, potent complexes support

Language: Английский

Citations

25

Targeted Covalent Modification Strategies for Drugging the Undruggable Targets DOI
Tomonori Tamura,

Masaharu Kawano,

Itaru Hamachi

et al.

Chemical Reviews, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 7, 2025

The term "undruggable" refers to proteins or other biological targets that have been historically challenging target with conventional drugs therapeutic strategies because of their structural, functional, dynamic properties. Drugging such undruggable is essential develop new therapies for diseases where current treatment options are limited nonexistent. Thus, investigating methods achieve drugging an important challenge in medicinal chemistry. Among the numerous methodologies drug discovery, covalent modification has emerged as a transformative strategy. attachment diverse functional molecules provides powerful platform creating highly potent and chemical tools well ability provide valuable information on structures dynamics targets. In this review, we summarize recent examples biomolecules development therapeutics overcome discovery challenges highlight how contribute toward particular, focus use chemistry drugs, identification, screening, artificial modulation post-translational modifications, cancer specific chemotherapies, nucleic acid-based therapeutics.

Language: Английский

Citations

1

Modulating the phosphorylation status of target proteins through bifunctional molecules DOI

Qindi He,

Zhijie Wang, Rongrong Wang

et al.

Drug Discovery Today, Journal Year: 2025, Volume and Issue: unknown, P. 104307 - 104307

Published: Feb. 1, 2025

Language: Английский

Citations

1

Platform Reagents Enable Synthesis of Ligand-Directed Covalent Probes: Study of Cannabinoid Receptor 2 in Live Cells DOI
Miroslav Kosar, David A. Sykes, Alexander E. G. Viray

et al.

Journal of the American Chemical Society, Journal Year: 2023, Volume and Issue: 145(28), P. 15094 - 15108

Published: July 4, 2023

Pharmacological modulation of cannabinoid receptor type 2 (CB2R) holds promise for the treatment neuroinflammatory disorders, such as Alzheimer's disease. Despite importance CB2R, its expression and downstream signaling are insufficiently understood in disease- tissue-specific contexts. Herein, we report first ligand-directed covalent (LDC) labeling CB2R enabled by a novel synthetic strategy application platform reagents. The LDC modification allows visualization study while maintaining ability to bind other ligands at orthosteric site. We employed silico docking molecular dynamics simulations guide probe design assess feasibility CB2R. demonstrate selective, peripheral lysine residue exploiting fluorogenic O-nitrobenzoxadiazole (O-NBD)-functionalized probes TR-FRET assay. rapid proof-of-concept validation with O-NBD inspired incorporation advanced electrophiles suitable experiments live cells. To this end, strategies toward N-sulfonyl pyridone (N-SP) N-acyl-N-alkyl sulfonamide (NASA) were developed, which allowed delivery fluorophores cellular studies. characterized radioligand binding assay experiments. Additionally, applied specifically visualize conventional imaging flow cytometry well confocal fluorescence microscopy using overexpressing endogenously expressing microglial

Language: Английский

Citations

23

Sulfamate Acetamides as Self-Immolative Electrophiles for Covalent Ligand-Directed Release Chemistry DOI Creative Commons
Rambabu Reddi,

Adi Rogel,

Ronen Gabizon

et al.

Journal of the American Chemical Society, Journal Year: 2023, Volume and Issue: 145(6), P. 3346 - 3360

Published: Feb. 4, 2023

Electrophiles for covalent inhibitors that are suitable in vivo administration rare. While acrylamides prevalent FDA-approved drugs, chloroacetamides considered too reactive such purposes. We report sulfamate-based electrophiles maintain chloroacetamide-like geometry with tunable reactivity. In the context of BTK inhibitor ibrutinib, sulfamate analogues showed low reactivity comparable potency protein labeling, vitro, and cellular kinase activity assays were effective a mouse model CLL. second example, we converted chloroacetamide Pin1 to potent selective acetamide improved buffer stability. Finally, show acetamides can be used ligand-directed release (CoLDR) chemistry, both generation "turn-on" probes as well traceless site-specific labeling proteins. Taken together, this chemistry represents promising addition list targeting.

Language: Английский

Citations

22

Proximity-inducing modalities: the past, present, and future DOI
Sameek Singh, Wenzhi Tian, Zachary C. Severance

et al.

Chemical Society Reviews, Journal Year: 2023, Volume and Issue: 52(16), P. 5485 - 5515

Published: Jan. 1, 2023

In this review, we highlight bifunctional modalities that perform functions other than degradation and have great potential to revolutionize disease treatment, while also serving as important tools in basic research explore new aspects of biology.

Language: Английский

Citations

17

Kinase-targeting small-molecule inhibitors and emerging bifunctional molecules DOI

Georg L. Goebel,

Xiaqiu Qiu,

Peng Wu

et al.

Trends in Pharmacological Sciences, Journal Year: 2022, Volume and Issue: 43(10), P. 866 - 881

Published: May 16, 2022

Language: Английский

Citations

28